Jan 28, 2020
FDA Accepts for Priority Review Dupixent® (dupilumab) for Children Aged 6 to 11 Years with Moderate-to-Severe Atopic Dermatitis
Jan 27, 2020
Lilly and Incyte Announce Top-Line Results from Phase 3 Study (BREEZE-AD4) of Oral Selective JAK Inhibitor Baricitinib in Combination with Topical Corticosteroids in Patients with Moderate to Severe Atopic Dermatitis Not Controlled with Cyclosporine
Jan 09, 2020
Gladskin Launches in USA - Micreos Scaling up to Deliver Award Winning Technology Worldwide
Dec 16, 2019
Kindred Biosciences Unveils Positive Results from Pilot Study of its Interleukin-4R Monoclonal Antibody Being Developed for the Treatment of Atopic Dermatitis in Dogs
Dec 09, 2019
Hoth Therapeutics And North Carolina State University Initiate Preclinical Gene Therapy Study For The Treatment Of Asthma
Dec 07, 2019
Janssen to Acquire Investigational Bermekimab from XBiotech
Nov 26, 2019
Hoth Therapeutics and North Carolina State University Enter License Agreement for Gene Therapy
Nov 12, 2019
EU-Funding: Micreos Awarded EUR2.5 Million for Breakthrough for Skin Problems Including Acne and Eczema
Nov 07, 2019
Survey Shows People Who First Developed Atopic Dermatitis Symptoms As Kids Experience More Severe Symptoms
Nov 07, 2019
Global Dermatitis Market Is Expected to Grow at a CAGR of Approximately 9% Over 2018-2022: The Business Research Company
Nov 04, 2019
Samsung Biologics and Ichnos Sciences Announce Agreement for Manufacture of ISB 830
Oct 30, 2019
DURECT Corporation to Announce Third Quarter 2019 Financial Results and Provide Business Update on November 4
Oct 28, 2019
Arena Pharmaceuticals Announces First Subject Dosed in ADVISE Phase 2 Trial Evaluating Etrasimod in Atopic Dermatitis
Oct 24, 2019
Merck Manuals Unveils Answers to Parents' Most Common Eczema Questions
Oct 24, 2019
Dr. Derek V. Chan, Dermatologist with Advanced Dermatology PC, Shares Tips on Five Common Rash-Causing Skin Conditions
Oct 14, 2019
Hoth Therapeutics Makes Donation to National Eczema Association in Sponsorship of "National Eczema Awareness Month"
Oct 10, 2019
2019 European Dermatological Congress: La Roche-Posay Presents Its Latest Research On Allergies, Atopic Dermatitis & Acne
Oct 08, 2019
Hoth Therapeutics Successfully Completes Phase I of In-Life Dose Escalation Study for Treating Eczema
Oct 03, 2019
Turn Therapeutics(TM) Closes Series B Round to Fuel Lead Atopic Dermatitis Program Trial and Pipeline Expansion
Oct 01, 2019
The National Eczema Association (NEA) Mobilizes Stakeholders To Expose The "Real" Eczema, A Life-Altering Skin Disease Affecting Over 31 Million Americans